Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Healthcare Industry News BD to acquire Edwards Lifesciences’ Critical Care product group for $4.2bn In a major strategic move, Becton, Dickinson and Company (NYSE: BDX), widely known as BD, has entered into… byPallavi MadhirajuJune 4, 2024